Skip to main content
Ravikumar Paluri, MD, Oncology, Winston Salem, NC

RavikumarPaluriMDMPH., FACP

Oncology Winston Salem, NC

Gastrointestinal Cancer

Associate Professor, The Atrium Health Wake Forest Baptist

Dr. Paluri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Paluri's full profile

Already have an account?

  • Office

    1 Medical Center Blvd
    Winston Salem, NC 27157
    Phone+1 336-713-3544

Summary

  • I am board certified Oncologist and Hematologist. Currently, I am holding the faculty title of Associate Professor of Medicine and Director of the Phase 1 program for Solid tumors. As Gastro-intestinal (GI) medical Oncology attending my clinical expertise is in providing care for patients receiving both standards of care and research treatments, as part of clinical trials, with a focus on gastrointestinal malignancies at the Atrium Health Wake Forest Baptist Health, an NCI, designated Comprehensive Cancer Center. As a clinical investigator, my research is focused on optimizing treatment selection and improving the outcomes of adults with Gastro-Intestinal cancers (esophageal, gastric, pancreas, bile duct, liver, small bowel, colorectal and anal cancers) with active involvement in Clinical trial designs, translational studies, and retrospective studies related to Gastrointestinal Malignancies. My clinical trial portfolio includes investigator-initiated trials, cooperative group trials, and industry-sponsored treatment studies. I have published over 50 articles on this topic and collaborated locally and nationally. Importantly, I am dedicated to providing unparalleled care to my patients by addressing all their needs giving time they need, and treating both patients and caregivers with compassion.

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 2009 - 2012
  • university of Alabama at Birmingham
    university of Alabama at BirminghamMPH, Epidemiology, 2007 - 2009
  • University of  Alabama
    University of AlabamaMPH, 2007 - 2009
  • Kakatiya Medical College NTR
    Kakatiya Medical College NTRClass of 2006

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2020 - 2025
  • AL State Medical License
    AL State Medical License 2009 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • American Board of Internal Medcine (ABIM)Board Certified in Hematology
  • American Board of Internal Medcine (ABIM)Board Certified in Oncology

Awards, Honors, & Recognition

  • FACP (Fellow of the American College of Physicians) ACP, 2016
  • Outstanding Clinical Fellow UAB, 2015
  • Nominated for Outstanding Medical Student Award 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Unique Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-center Experience and Literature Review  
    Paluri, R., Nabell, L., Borak, S. and Peker, D., Hematol. Oncol.., 1/1/2014
  • Kinetics of Chimerism and Early Immune Recovery in Patients Receiving Unmodified Peripheral Blood Allogeneic Grafts Followed by Post-HSCT Cyclophosphamide for GvHD Pro...  
    Paluri R, Lamb L, Cloud, G, Mineishi S, Biol. Blood & Marrow Transplantation, 1/1/2014
  • Anti Factor Xa Assay for Effective Monitoring of Heparin: A Case Report  
    Paluri R, Koya S, Marques M, Journal of General Internal Medicine (JGIM), 6/1/2010

Abstracts/Posters

  • A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...
    Ravi K. Paluri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Kinetics of Chimerism and Early Immune Recovery in Patients Receiving Unmodified Peripheral Blood Allogeneic Grafts Followed By Post-HSCT High Dose Cyclophosphamide fo...
    Paluri R, Mineishi S, Lamb L, ASBMT, Grapevine, TX, 2/1/2014
  • The Influence of Vitamin D and Receptor Status in Colorectal Cancer
    Paluri R, Manne U, Putcha B, Jadhav T, Council L, Posey J, GI ASCO, 1/1/2014
  • Join now to see all

Lectures

  • Phase1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Physical Activity and Cancer Survival 
    UAB School of Medicine - 12/1/2013
  • Stem Cell Transplantation in Sickle Cell Disease 
    2/1/2013

Other

  • Post-transplant Lymphoproliferative Disorders. Systematic Review, Thesis for Masters in Public Health 
    Paluri R, Brown E
    1/1/2009

Professional Memberships

Other Languages

  • Telugu, Hindi